Nihon Kohden (OTCMKTS:NHNKY) & PetVivo (NASDAQ:PETV) Head to Head Analysis

Nihon Kohden (OTCMKTS:NHNKY) and PetVivo (NASDAQ:PETV) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Earnings and Valuation

This table compares Nihon Kohden and PetVivo”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nihon Kohden	$1.56 billion	0.98	$95.79 million	$0.59	15.47
PetVivo	$1.05 million	23.58	-$10.95 million	($0.38)	-1.71

Nihon Kohden has higher revenue and earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Nihon Kohden, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

0.1% of Nihon Kohden shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Nihon Kohden and PetVivo’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nihon Kohden	5.90%	9.08%	6.37%
PetVivo	-902.82%	-4,813.07%	-281.78%

Analyst Ratings

This is a summary of current ratings and target prices for Nihon Kohden and PetVivo, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nihon Kohden	0	1	0	1	3.00
PetVivo	0	0	0	0	0.00

Volatility and Risk

Nihon Kohden has a beta of 0.37, suggesting that its stock price is 63% less volatile than the S&P 500. Comparatively, PetVivo has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500.

Summary

Nihon Kohden beats PetVivo on 9 of the 13 factors compared between the two stocks.

About Nihon Kohden

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.

About PetVivo

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.